BENEFIX
BENEFIX
Approved
DIN Number
02293803
Drug Class
Human
Market Date
Jul 12, 2008
Company
HC
Pfizer Canada Ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02293803
AIG Number0152202004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
B02BD04 COAGULATION FACTOR IX
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification20:28.16
Health Canada Classification
ACTIVE INGREDIENTS (1)
COAGULATION FACTOR IX (RECOMBINANT)Active
Strength: 2000 UNIT / VIAL
Monograph: COAGULATION FACTOR IX (RECOMBINANT)